CAMP and ovarian carcinoma: The demonstration that LL-37 acts on MSC migration has been revealed in a mice model of ovarian cancer, where LL-37 neutralization reduced the engraftment of MSCs in the tumor and lead to the inhibition of cancer progression [36].